Strategic Collaborations Ampio recently partnered with H.C. Wainwright & Co., indicating openness to advisory and co-development opportunities. This presents a chance to offer strategic finance, advisory, or partnership solutions to accelerate fundraising, licensing discussions, or collaborative research initiatives aligned with their near-term capital or deal-making needs.

Regulatory & Litigation Readiness Past class action litigation exposure suggests heightened regulatory and legal scrutiny around disclosures and investor communications. Sales potential exists for compliance, investor relations, and disclosure management tools or services that help them mitigate risk and enhance transparency with stakeholders.

Board & Leadership Activity Ongoing board and executive changes, including added directors and leadership shifts, indicate a dynamic governance environment. This creates opportunities to engage in executive search, governance advisory, succession planning, or leadership-focused training and enablement services.

Scale & Financial Profile With small employee count but multi-million revenue and substantial funding, Ampio is likely seeking scalable solutions that optimize operations and accelerate research timelines without large overhead. Consider offering lightweight, cloud-based R&D, data analytics, or GMP-compliant tooling that delivers high ROI with limited headcount.

Biotech Niche Focus Specialization in immunomodulatory therapies for inflammatory conditions positions Ampio within a market that rewards partnerships in clinical development, regulatory strategy, and CRO/CMO collaboration. Upsell opportunities include clinical trial support services, biomarker analytics, and manufacturing process support tailored to small biotech players.